Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Breast Implant and Reconstruction, and Global Cancer Incidence and Screening.
Survival Disparities in Patients With Metastatic Breast Cancer.
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.
Risk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 Neu-Negative Invasive Breast Cancer.
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ
Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
Transforming the Future of Surgeon-Scientists
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
Learning to distinguish progressive and non-progressive ductal carcinoma in situ
Malignant phyllodes tumor and primary breast sarcoma; distinct rare tumors of the breast
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.
Mobile Health Application for Patients Undergoing Breast Cancer Surgery: Feasibility Study.
Outcomes and Costs for Women After Breast Cancer: Preparing for Improved Survivorship of Medicare Beneficiaries.
Patient Preferences for Outcomes Following DCIS Management Strategies: A Discrete Choice Experiment.
Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change
Ductal carcinoma in situ: to treat or not to treat, that is the question
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ
Classifying the evolutionary and ecological features of neoplasms
Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration
Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression
Survival after lumpectomy and mastectomy for early stage invasive breast cancer
Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer
Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27+ Cell Population with Progenitor Characteristics
Impact of Ductal Carcinoma In Situ Terminology on Patient Treatment Preferences